{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:58:52Z","timestamp":1792828732379,"version":"4.5.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11102-022-01289-x","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T18:20:11Z","timestamp":1669314011000},"page":"73-93","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Post-operative surveillance for somatotroph, lactotroph and non-functional pituitary adenomas after curative resection: a systematic review"],"prefix":"10.1007","volume":"26","author":[{"given":"Lisa","family":"Caulley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorsa","family":"Mavedatnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Sahlollbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Amrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Anne","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Malcolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Alkherayf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Johnson-Obaseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam G. M.","family":"Hunink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun J.","family":"Kilty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"issue":"4","key":"1289_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ncl.2007.07.003","volume":"25","author":"J Jagannathan","year":"2007","unstructured":"Jagannathan J, Kanter A, Sheehan J, Jane J, Laws E (2007) Benign brain tumors: Sellar\/parasellar tumors. Neurol Clin 25(4):1231\u20131249","journal-title":"Neurol Clin"},{"issue":"9","key":"1289_CR2","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/alr.21356","volume":"4","author":"J Villwock","year":"2014","unstructured":"Villwock J, Villwock M, Deshaies E, Goyal P (2014) Significant increases of pituitary tumors and resections from 1993 to 2011. Int Forum Allergy Rhinol 4(9):767\u2013770","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"1289_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","volume":"49","author":"A Daly","year":"2020","unstructured":"Daly A, Beckers A (2020) The epidemiology of pituitary adenomas. Endocrinol Metab Clin North Am 49(3):347\u2013355","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9","key":"1289_CR4","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41379-021-00820-y","volume":"34","author":"S Asa","year":"2021","unstructured":"Asa S, Mete O, Cusimano M et al (2021) Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification. Mod Pathol 34(9):1634\u20131650","journal-title":"Mod Pathol"},{"key":"1289_CR5","first-page":"11","volume-title":"Who classification of tumours of endocrine organs","author":"Tumors of the pituitary gland","year":"2017","unstructured":"Tumors of the pituitary gland (2017). In: Lloyd R, Osamura R, Kloppel G, Rosai J (eds) Who classification of tumours of endocrine organs, 4th edn. International Agency for Research on Cancer, Lyon, pp 11\u201364","edition":"4"},{"issue":"5","key":"1289_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"M Molitch","year":"2017","unstructured":"Molitch M (2017) Diagnosis and treatment of pituitary adenomas. JAMA 317(5):516\u2013524","journal-title":"JAMA"},{"key":"1289_CR7","first-page":"1683","volume":"20","author":"N Luongo","year":"2019","unstructured":"Luongo N, Slivinski P, Smith A, Lovinaria D (2019) Neurosurgery and pituitary resection in cancer patients. Oncologic Critical Care 20:1683\u20131692","journal-title":"Oncologic Critical Care"},{"issue":"11","key":"1289_CR8","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1210\/jcem.84.11.6202","volume":"84","author":"P Freda","year":"1999","unstructured":"Freda P, Wardlaw S (1999) Diagnosis and treatment of pituitary tumors. J Clin Endocrinol Metab 84(11):3859\u20133866","journal-title":"J Clin Endocrinol Metab"},{"key":"1289_CR9","unstructured":"Jane J Jr, Catalino M, Laws E Jr. Surgical Treatment of Pituitary Adenomas. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA). 2000."},{"issue":"4","key":"1289_CR10","doi-asserted-by":"publisher","first-page":"E533","DOI":"10.1227\/NEU.0000000000001389","volume":"79","author":"J Lucas","year":"2016","unstructured":"Lucas J, Bodach M, Tumialan L et al (2016) Congress of Neurological Surgeons systematic review and evidence-based guideline on primary management of patients with nonfunctioning pituitary adenomas. Neurosurgery 79(4):E533-535","journal-title":"Neurosurgery"},{"issue":"1","key":"1289_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/EJE-07-0248","volume":"158","author":"J Kreutzer","year":"2008","unstructured":"Kreutzer J, Buslei R, Wallaschofski H et al (2008) Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol 158(1):11\u201318","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1289_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/EJE-18-0749","volume":"180","author":"S Asioli","year":"2019","unstructured":"Asioli S, Righi A, Iommi M et al (2019) Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: Retrospective analysis on 566 patients from a tertiary care centre. Eur J Endocrinol 180(2):127\u2013134","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1289_CR13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1530\/EJE-11-0566","volume":"165","author":"R Reddy","year":"2011","unstructured":"Reddy R, Cudlip S, Byrne J, Karavitaki N, Wass J (2011) Can we ever stop imaging in surgically treated and radiotherapy-na\u00efve patients with non-functioning pituitary adenoma? Eur J Endocrinol 165(5):739\u2013744","journal-title":"Eur J Endocrinol"},{"issue":"05","key":"1289_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1055\/s-0035-1549307","volume":"76","author":"H Kistka","year":"2015","unstructured":"Kistka H, Kasl R, Nayeri A, Utz A, Weaver K, Chambless L (2015) Imaging of resected nonfunctioning pituitary adenomas: the cost of surveillance. J Neurol Surgery Part B 76(05):344\u2013350","journal-title":"J Neurol Surgery Part B"},{"issue":"3","key":"1289_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4158\/EP.7.3.170","volume":"7","author":"L Wilson","year":"2001","unstructured":"Wilson L, Shin L, Ezzat S (2001) Longitudinal assessment of economic burden and clinical outcomes in acromegaly. Endocr Pract 7(3):170\u2013180","journal-title":"Endocr Pract"},{"issue":"1","key":"1289_CR16","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0796","volume":"178","author":"G Raverot","year":"2018","unstructured":"Raverot G, Burman P, McCormack A et al (2018) European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178(1):G1-24","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1289_CR17","first-page":"319","volume":"88","author":"M Lake","year":"2013","unstructured":"Lake M, Krook L, Cruz S (2013) Pituitary adenomas: an overview. Am Fam Phys 88(5):319\u2013327","journal-title":"Am Fam Phys"},{"issue":"1","key":"1289_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","volume":"126","author":"J Trouillas","year":"2013","unstructured":"Trouillas J, Roy P, Sturm N et al (2013) A new prognostic clinicopathological classfication of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126(1):123\u2013135","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1289_CR19","doi-asserted-by":"publisher","first-page":"E541","DOI":"10.1227\/NEU.0000000000001392","volume":"79","author":"M Ziu","year":"2016","unstructured":"Ziu M, Dunn I, Hess C et al (2016) Congress of Neurological Surgeons systematic review and evidence-based guideline on posttreatment follow-up evaluation of patients with nonfunctioning pituitary adenomas. Neurosurgery 79(4):E541-543","journal-title":"Neurosurgery"},{"issue":"3","key":"1289_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"O Mete","year":"2017","unstructured":"Mete O, Lopes M (2017) Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol 28(3):228\u2013243","journal-title":"Endocr Pathol"},{"key":"1289_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"J Higgins","year":"2019","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, Welch V (2019) Cochrane handbook for systematic reviews of interventions, 2nd edn. Wiley, Chichester","edition":"2"},{"issue":"4","key":"1289_CR22","first-page":"264","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman D (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 151(4):264\u2013269","journal-title":"BMJ"},{"key":"1289_CR23","first-page":"88","volume":"2021","author":"M Page","year":"2020","unstructured":"Page M, McKenzie J, Bossuyt P, The PRISMA et al (2020) statement: An updated guideline for reporting systematic reviews. Int J Surg 2021:88","journal-title":"Int J Surg"},{"issue":"1","key":"1289_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-0038-1625984","volume":"79","author":"A Perry","year":"2018","unstructured":"Perry A, Graffeo CS, Marcellino C, Pollock BE, Wetjen NM, Meyer FB (2018) Pediatric pituitary adenoma: case series, review of the literature, and a skull base treatment paradigm. J Neurol Surgery Part B 79(1):91\u2013114","journal-title":"J Neurol Surgery Part B"},{"issue":"1","key":"1289_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.wneu.2012.05.032","volume":"79","author":"M Hlavica","year":"2013","unstructured":"Hlavica M, Bellut D, Lemm D, Schmid C, Bernays RL (2013) Impact of ultra-low-field intraoperative magnetic resonance imaging on extent of resection and frequency of tumor recurrence in 104 surgically treated nonfunctioning pituitary adenomas. World Neurosurg 79(1):99\u2013109","journal-title":"World Neurosurg"},{"key":"1289_CR26","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1016\/j.wneu.2018.08.043","volume":"120","author":"R Batista","year":"2018","unstructured":"Batista R, Trarbach E, Marques M et al (2018) Nonfunctioning pituitary adenoma recurrence and its relationship with sex, size, and hormonal immunohistochemical profile. World Neurosurg 120:e241\u2013e246","journal-title":"World Neurosurg"},{"issue":"5","key":"1289_CR27","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1365-2265.1994.tb01832.x","volume":"41","author":"K Bradley","year":"1994","unstructured":"Bradley K, Adams C, Potter C, Wheeler D, Anslow P, Burke C (1994) An audit of selected patients with non-functioning pituitary adenoma treated by transsphenoidal surgery without irradiation. Clin Endocrinol 41(5):655\u2013659","journal-title":"Clin Endocrinol"},{"issue":"2","key":"1289_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1530\/EJE-10-0255","volume":"163","author":"S Brochier","year":"2010","unstructured":"Brochier S, Galland F, Kujas M et al (2010) Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients. Eur J Endocrinol 163(2):193\u2013200","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1289_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11102-010-0221-z","volume":"13","author":"E Chang","year":"2010","unstructured":"Chang E, Sughrue M, Zada G, Wilson C, Blevins L, Kunwar S (2010) Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas. Pituitary 13(3):223\u2013229","journal-title":"Pituitary"},{"key":"1289_CR30","doi-asserted-by":"publisher","first-page":"e1024","DOI":"10.1016\/j.wneu.2019.05.066","volume":"128","author":"W-C Deng","year":"2019","unstructured":"Deng W-C, Yan J-L, Chuang C-C et al (2019) Adjuvant radiation therapy compared with observation alone for postoperative residual nonfunctional pituitary adenomas. World Neurosurg 128:e1024\u2013e1033. https:\/\/doi.org\/10.1016\/j.wneu.2019.05.066","journal-title":"World Neurosurg"},{"issue":"3","key":"1289_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1530\/EJE-18-0291","volume":"179","author":"B Galm","year":"2018","unstructured":"Galm B, Martinez-Salazar E, Swearingen B et al (2018) MRI texture analysis as a predictor of tumor recurrence or progression in patients with clinically non-functioning pituitary adenomas. Eur J Endocrinol 179(3):191\u2013198","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1289_CR32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3171\/2019.11.JNS192457","volume":"134","author":"M Gerges","year":"2021","unstructured":"Gerges M, Rumalla K, Godil S et al (2021) Long-term outcomes after endoscopic endonasal surgery for nonfunctioning pituitary macroadenomas. J Neurosurg 134(2):535\u2013546","journal-title":"J Neurosurg"},{"issue":"3","key":"1289_CR33","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3171\/2016.3.JNS152735","volume":"126","author":"C Przybylowski","year":"2017","unstructured":"Przybylowski C, Dallapiazza R, Williams B et al (2017) Primary versus revision transsphenoidal resection for nonfunctioning pituitary macroadenomas: Matched Cohort Study. J Neurosurg 126(3):889\u2013896","journal-title":"J Neurosurg"},{"issue":"3","key":"1289_CR34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/00006123-199809000-00020","volume":"43","author":"K Lillehei","year":"1998","unstructured":"Lillehei K, Kirschman D, Kleinschmidt-DeMasters B, Ridgway E (1998) Reassessment of the role of radiation therapy in the treatment of endocrine-inactive pituitary macroadenomas. Neurosurgery 43(3):432\u2013438","journal-title":"Neurosurgery"},{"issue":"4","key":"1289_CR35","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.3892\/mmr.2017.6169","volume":"15","author":"C Liu","year":"2017","unstructured":"Liu C, Wu Y, Yu S et al (2017) Increased \u03b2-catenin and c-myc expression predict aggressive growth of non-functioning pituitary adenomas: an assessment using a tissue microarray-based approach. Mol Med Rep 15(4):1793\u20131799","journal-title":"Mol Med Rep"},{"issue":"10","key":"1289_CR36","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1210\/js.2019-00163","volume":"3","author":"J Maletkovic","year":"2019","unstructured":"Maletkovic J, Dabbagh A, Zhang D et al (2019) Residual tumor confers a 10-fold increased risk of regrowth in clinically nonfunctioning pituitary tumors. J Endocr Soc 3(10):1931\u20131941. https:\/\/doi.org\/10.1210\/js.2019-00163","journal-title":"J Endocr Soc"},{"issue":"1","key":"1289_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jocn.2010.04.049","volume":"18","author":"N Nakao","year":"2011","unstructured":"Nakao N, Itakura T (2011) Surgical outcome of the endoscopic endonasal approach for non-functioning giant pituitary adenoma. J Clin Neurosci 18(1):71\u201375","journal-title":"J Clin Neurosci"},{"issue":"6","key":"1289_CR38","first-page":"7121","volume":"14","author":"S Park","year":"2017","unstructured":"Park S, Jang J, Lee Y, Kim J, Kim K, Kim Y (2017) Function of cell-cycle regulators in predicting silent pituitary adenoma progression following surgical resection. Oncol Lett 14(6):7121\u20137130","journal-title":"Oncol Lett"},{"issue":"3","key":"1289_CR39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1046\/j.1365-2265.1999.00865.x","volume":"51","author":"H Turner","year":"1999","unstructured":"Turner H, Stratton I, Byrne J, Adams C, Wass J (1999) Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - a follow-up study. Clin Endocrinol 51(3):281\u2013284","journal-title":"Clin Endocrinol"},{"issue":"5","key":"1289_CR40","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1227\/01.NEU.0000088660.16904.F7","volume":"53","author":"K Webb","year":"2003","unstructured":"Webb K, Laurent J, Okonkwo D, Lopes M, Vance M, Laws E (2003) Clinical characteristics of silent corticotrophic adenomas and creation of an internet-accessible database to facilitate their multi-institutional study. Neurosurgery 53(5):1076\u20131085","journal-title":"Neurosurgery"},{"key":"1289_CR41","doi-asserted-by":"publisher","first-page":"e925","DOI":"10.1016\/j.wneu.2019.04.001","volume":"127","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Yang K, Xia Y, Meng X, Yu X (2019) High-field intraoperative magnetic resonance imaging increases extent of resection and progression-free survival for nonfunctioning pituitary adenomas. World Neurosurg 127:e925\u2013e931","journal-title":"World Neurosurg"},{"issue":"3","key":"1289_CR42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/cen.13791","volume":"89","author":"M Levy","year":"2018","unstructured":"Levy M, Robertson I, Khalk N et al (2018) Long-term follow-up of a large prospective cohort of patients with nonfunctioning pituitary adenomas: the outcome of a conservative management policy. Clin Endocrinol 89(3):354\u2013359","journal-title":"Clin Endocrinol"},{"issue":"2","key":"1289_CR43","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00006123-199902000-00006","volume":"44","author":"J Tyrrell","year":"1999","unstructured":"Tyrrell J, Lamborn K, Hannegan L, Applebury C, Wilson C (1999) Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results. Neurosurgery 44(2):254\u2013261","journal-title":"Neurosurgery"},{"issue":"2","key":"1289_CR44","first-page":"152","volume":"26","author":"B Schaller","year":"2005","unstructured":"Schaller B (2005) Gender-related differences in prolactinomas: a clinicopathological study. Neuroendocrinol Lett 26(2):152\u2013159","journal-title":"Neuroendocrinol Lett"},{"issue":"6","key":"1289_CR45","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1210\/jcem-57-6-1270","volume":"57","author":"F Camanni","year":"1983","unstructured":"Camanni F, Ghigo E, Ciccarelli E et al (1983) Defective regulation of prolactin secretion after successful removal of prolactinomas. J Clin Endocrinol Metab 57(6):1270\u20131276","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1289_CR46","first-page":"65","volume":"45","author":"S Acquati","year":"2001","unstructured":"Acquati S, Pizzocaro A, Tomei G et al (2001) A comparative evaluation of effectiveness of medical and surgical therapy in patients with macroprolactinoma. J Neurol Sci 45(2):65\u201369","journal-title":"J Neurol Sci"},{"issue":"2","key":"1289_CR47","first-page":"141","volume":"54","author":"D Gordon","year":"1985","unstructured":"Gordon D, Richards A, Bulloch R et al (1985) Prolactin dynamics and tumour size in the prediction of surgical outcome for Prolactinoma. QJM 54(2):141\u2013151","journal-title":"QJM"},{"issue":"3","key":"1289_CR48","first-page":"259","volume":"125","author":"T Hirohata","year":"1991","unstructured":"Hirohata T, Uozumi T, Mukada K et al (1991) Influence of pregnancy on the serum prolactin level following prolactinoma surgery. Acta Endocrinol 125(3):259\u2013267","journal-title":"Acta Endocrinol"},{"issue":"1","key":"1289_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4158\/EP161446.OR","volume":"23","author":"D Donegan","year":"2017","unstructured":"Donegan D, Atkinson J, Jentoft M et al (2017) Surgical outcomes of prolactinomas in recent era: results of a heterogenous group. Endocr Pract 23(1):37\u201345","journal-title":"Endocr Pract"},{"issue":"10","key":"1289_CR50","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0026-0495(86)90052-1","volume":"35","author":"B Arafah","year":"1986","unstructured":"Arafah B, Brodkey J, Pearson O (1986) Gradual recovery of lactotroph responsiveness to dynamic stimulation following surgical removal of prolactinomas: Long-term follow-up studies. Metabolism 35(10):905\u2013912","journal-title":"Metabolism"},{"issue":"1","key":"1289_CR51","first-page":"36","volume":"50","author":"J Thomson","year":"2002","unstructured":"Thomson J, Gray C, Teasdale G (2002) Relapse of hyperprolactinemia after transsphenoidal surgery for microprolactinoma: Lessons from long-term follow-up. Neurosurgery 50(1):36\u201340","journal-title":"Neurosurgery"},{"issue":"5","key":"1289_CR52","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1056\/NEJM198308043090505","volume":"309","author":"O Serri","year":"1983","unstructured":"Serri O, Rasio E, Beauregard H, Hardy J, Somma M (1983) Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with Prolactinoma. N Engl J Med 309(5):280\u2013283","journal-title":"N Engl J Med"},{"issue":"2","key":"1289_CR53","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/BF02989660","volume":"9","author":"B Merola","year":"1992","unstructured":"Merola B, Colao A, Panza N et al (1992) Clinical management of prolactinomas: a ten-Year experience. Med Oncol Tumor Pharmacother 9(2):93\u201399","journal-title":"Med Oncol Tumor Pharmacother"},{"issue":"4","key":"1289_CR54","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0090-3019(95)00430-0","volume":"45","author":"F Massoud","year":"1996","unstructured":"Massoud F, Serri O, Hardy J, Somma M, Beauregard H (1996) Transsphenoidal adenomectomy for microprolactinomas: 10 to 20 years of follow-up. Surg Neurol 45(4):341\u2013346","journal-title":"Surg Neurol"},{"issue":"1","key":"1289_CR55","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0002-9378(79)90795-6","volume":"134","author":"R Wiebe","year":"1979","unstructured":"Wiebe R, Kramer R, Hammond C (1979) Surgical treatment of prolactin-secreting microadenomas. Am J Obstet Gynecol 134(1):49\u201355","journal-title":"Am J Obstet Gynecol"},{"issue":"6508","key":"1289_CR56","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1136\/bmj.291.6508.1547","volume":"291","author":"M Scanlon","year":"1985","unstructured":"Scanlon M, Peters J, Thomas J et al (1985) Management of selected patients with hyperprolactinaemia by partial hypophysectomy. BMJ 291(6508):1547\u20131550","journal-title":"BMJ"},{"issue":"7","key":"1289_CR57","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/jama.1984.03350070039020","volume":"252","author":"E Rodman","year":"1984","unstructured":"Rodman E, Molitch M, Post K, Biller B, Reichlin S (1984) Long-term follow-up of transsphenoidal selective adenomectomy for Prolactinoma. JAMA 252(7):921\u2013924","journal-title":"JAMA"},{"issue":"5","key":"1289_CR58","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1365-2265.1990.tb00901.x","volume":"32","author":"E Ciccarelli","year":"1990","unstructured":"Ciccarelli E, Ghigo E, Miola C, Gandini G, Muller E, Camanni F (1990) Long-term follow-up of \u2018cured\u2019 prolactinoma patients after successful adenomectomy. Clin Endocrinol 32(5):583\u2013592","journal-title":"Clin Endocrinol"},{"issue":"5","key":"1289_CR59","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1365-2265.1987.tb00809.x","volume":"26","author":"J Bevan","year":"1987","unstructured":"Bevan J, Adams C, Burke C et al (1987) Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including preoperative bromocriptine therapy. Clin Endocrinol 26(5):541\u2013556","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1289_CR60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-2265.1992.tb02900.x","volume":"36","author":"J Webster","year":"1992","unstructured":"Webster J, Page M, Bevan J, Richards S, Douglas-Jones A, Scanlon M (1992) Low recurrence rate after partial hypophysectomyfor prolactinoma: The predictive value ofdynamic prolactin function tests. Clin Endocrinol 36(1):35\u201344","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1289_CR61","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1210\/edrv-1-3-295","volume":"1","author":"J Schlechte","year":"1980","unstructured":"Schlechte J, Sherman B, Halmi N et al (1980) Prolactin-secreting pituitary tumors in Amenorrheic women: a comprehensive study. Endocr Rev 1(3):295\u2013308","journal-title":"Endocr Rev"},{"issue":"10","key":"1289_CR62","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1210\/jcem.83.10.5111","volume":"83","author":"A Abosch","year":"1998","unstructured":"Abosch A, Tyrrell J, Lamborn K, Hannegan L, Applebury C, Wilson C (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: Initial outcome and long-term results. J Clin Endocrinol Metab 83(10):3411\u20133418","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1289_CR63","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1046\/j.1365-2265.2003.01679.x","volume":"58","author":"C Beauregard","year":"2003","unstructured":"Beauregard C, Truong U, Hardy J, Serri O (2003) Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol 58(1):86\u201391","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1289_CR64","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1046\/j.1365-2265.2002.01465.x","volume":"56","author":"N Biermasz","year":"2002","unstructured":"Biermasz N, Smit J, Van Dulken H, Roelfsema F (2002) Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly. Clin Endocrinol 56(3):313\u2013319","journal-title":"Clin Endocrinol"},{"issue":"5","key":"1289_CR65","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-2265.1978.tb02171.x","volume":"8","author":"G Faglia","year":"1978","unstructured":"Faglia G, Paracchi A, Ferrari C, Beck-Peccoz P (1978) Evaluation of the results of trans-sphenoidal surgery in acromegaly by assessment of the growth hormone response to thyrotrophin-releasing hormone. Clin Endocrinol 8(5):373\u2013380","journal-title":"Clin Endocrinol"},{"issue":"4","key":"1289_CR66","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1046\/j.1365-2265.1996.8370847.x","volume":"45","author":"R Sheaves","year":"1996","unstructured":"Sheaves R, Jenkins P, Blackburn P et al (1996) Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Clin Endocrinol 45(4):407\u2013413","journal-title":"Clin Endocrinol"},{"issue":"10","key":"1289_CR67","first-page":"3419","volume":"83","author":"B Swearingen","year":"1998","unstructured":"Swearingen B, Barker F, Katznelson L et al (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83(10):3419\u20133426","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1289_CR68","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1046\/j.1365-2796.2000.00667.x","volume":"247","author":"S Valdemarsson","year":"2000","unstructured":"Valdemarsson S, Ljunggren S, Bramnert M, Norrhamn O, Nordstrom C (2000) Early postoperative growth hormone levels: High predictive value for long-term outcome after surgery for acromegaly. J Intern Med 247(6):640\u2013650","journal-title":"J Intern Med"},{"issue":"1","key":"1289_CR69","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0090-3019(89)90213-9","volume":"31","author":"S Yamada","year":"1989","unstructured":"Yamada S, Aiba T, Shishiba Y (1989) Postoperative prognostic indicators of control of acromegaly. Surg Neurol 31(1):14\u201319","journal-title":"Surg Neurol"},{"issue":"4","key":"1289_CR70","doi-asserted-by":"publisher","first-page":"360","DOI":"10.5812\/Kowsar.1726913X.2125","volume":"9","author":"Z Annabestani","year":"2011","unstructured":"Annabestani Z, Mohajeri-Tehrani M, Tabatabaie-Malazy O et al (2011) Assessment of influencing factors on outcome of transsphenoidal surgery in Acromegalic patients. Int J Endocrinol Metab 9(4):360\u2013363","journal-title":"Int J Endocrinol Metab"},{"issue":"2","key":"1289_CR71","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/neuros\/nyx020","volume":"81","author":"H Babu","year":"2017","unstructured":"Babu H, Ortega A, Nuno M et al (2017) Long-term endocrine outcomes following endoscopic endonasal transsphenoidal surgery for acromegaly and associated prognostic factors. Neurosurgery 81(2):357\u2013366","journal-title":"Neurosurgery"},{"issue":"3","key":"1289_CR72","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1210\/jc.2004-1974","volume":"90","author":"C Ronchi","year":"2005","unstructured":"Ronchi C, Varca V, Giavoli C et al (2005) Long-term evaluation of postoperative acromegalic patients in remission with previous and newly proposed criteria. J Clin Endocrinol Metab 90(3):1377\u20131382","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1289_CR73","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1210\/jcem-61-6-1185","volume":"61","author":"O Serri","year":"1985","unstructured":"Serri O, Somma M, Comtois R et al (1985) Acromegaly: Biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy. J Clin Endocrinol Metab 61(6):1185\u20131189","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1289_CR74","first-page":"1239","volume":"48","author":"I Shimon","year":"2001","unstructured":"Shimon I, Cohen Z, Ram Z, Hadani M (2001) Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48(6):1239\u20131245","journal-title":"Neurosurgery"},{"issue":"9","key":"1289_CR75","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1210\/jc.2003-032141","volume":"89","author":"E Zirkzee","year":"2004","unstructured":"Zirkzee E, Corssmit E, Biermasz N et al (2004) Pituitary magnetic resonance imaging is not required in the postoperative follow-up of acromegalic patients with long-term biochemical cure after transsphenoidal surgery. J Clin Endocrinol Metab 89(9):4320\u20134324","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1289_CR76","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00701-010-0790-7","volume":"153","author":"R Kristof","year":"2010","unstructured":"Kristof R, Grote A, Redel L, Neuloh G, Klingm\u00fcller D, Schramm J (2010) The common consensus criteria have high predictive values for long-term postoperative acromegaly remission. Acta Neurochir 153(1):19\u201325","journal-title":"Acta Neurochir"},{"issue":"7","key":"1289_CR77","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00701-011-0959-8","volume":"153","author":"M Wagenmakers","year":"2011","unstructured":"Wagenmakers M, Netea-Maier R, van Lindert E, Pieters G, Grotenhuis A, Hermus A (2011) Results of endoscopic transsphenoidal pituitary surgery in 40 patients with a growth hormone-secreting macroadenoma. Acta Neurochir 153(7):1391\u20131399","journal-title":"Acta Neurochir"},{"issue":"5","key":"1289_CR78","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s007010200064","volume":"144","author":"P Kremer","year":"2002","unstructured":"Kremer P, Forsting M, Ranaei G et al (2002) Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma. Acta Neurochir 144(5):433\u2013443","journal-title":"Acta Neurochir"},{"issue":"6","key":"1289_CR79","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3171\/2013.8.JNS13790","volume":"119","author":"S Berkmann","year":"2013","unstructured":"Berkmann S, Schlaffer S, Buchfelder M (2013) Tumor shrinkage after transsphenoidal surgery for nonfunctioning pituitary adenoma. J Neurosurg 119(6):1447\u20131452","journal-title":"J Neurosurg"},{"issue":"5","key":"1289_CR80","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1210\/jc.2005-2552","volume":"91","author":"O Dekkers","year":"2006","unstructured":"Dekkers O, Pereira A, Roelfsema F et al (2006) Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91(5):1796\u20131801","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1289_CR81","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1227\/NEU.0000000000000563","volume":"76","author":"R Dallapiazza","year":"2015","unstructured":"Dallapiazza R, Grober Y, Starke R, Laws E, Jane J (2015) Long-term results of endonasal endoscopic transsphenoidal resection of nonfunctioning pituitary macroadenomas. Neurosurgery 76(1):42\u201353","journal-title":"Neurosurgery"},{"issue":"11","key":"1289_CR82","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1210\/jc.2009-0471","volume":"94","author":"T-W Noh","year":"2009","unstructured":"Noh T-W, Jeong H, Lee M-K, Kim T, Kim S, Lee E (2009) Predicting recurrence of nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 94(11):4406\u20134413","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1289_CR83","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3171\/2014.10.JNS14372","volume":"123","author":"J Gondim","year":"2015","unstructured":"Gondim J, Almeida J, de Albuquerque L, Gomes E, Schops M, Mota J (2015) Endoscopic endonasal transsphenoidal surgery in elderly patients with pituitary adenomas. J Neurosurg 123(1):31\u201338","journal-title":"J Neurosurg"},{"issue":"02","key":"1289_CR84","first-page":"125","volume":"78","author":"C Zygourakis","year":"2016","unstructured":"Zygourakis C, Imber B, Chen R et al (2016) Cost-effectiveness analysis of surgical versus medical treatment of prolactinomas. J NeurolSurgery Part B 78(02):125\u2013131","journal-title":"J NeurolSurgery Part B"},{"issue":"3","key":"1289_CR85","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/archotol.1995.01890030051008","volume":"121","author":"B Petruson","year":"1995","unstructured":"Petruson B, Jakobsson K, Elfverson J, Bengtsson B (1995) Five-year follow-up of nonsecreting pituitary adenomas. Arch Otolaryngol Head Neck Surg 121(3):317\u2013322","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"7","key":"1289_CR86","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/BF03346346","volume":"30","author":"M Luque-Ramirez","year":"2007","unstructured":"Luque-Ramirez M, Paramo C, da Costa CV, Garc\u00eda-Mayor R (2007) Cost of management of invasive growth hormone-secreting macroadenoma. J Endocrinoll Invest 30(7):541\u2013545","journal-title":"J Endocrinoll Invest"},{"issue":"4","key":"1289_CR87","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2165\/11599680-000000000-00000","volume":"32","author":"M Roset","year":"2012","unstructured":"Roset M, Merino-Montero S, Luque-Ram\u00edrez M et al (2012) Cost of clinical management of acromegaly in Spain. Clin Drug Investig 32(4):235\u2013245","journal-title":"Clin Drug Investig"},{"issue":"2","key":"1289_CR88","first-page":"526","volume":"85","author":"A Giustina","year":"2000","unstructured":"Giustina A, Barkan A, Casanueva F et al (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85(2):526\u2013529","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1289_CR89","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws E, Melmed S et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1289_CR90","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3171\/jns.2002.97.2.0307","volume":"97","author":"A Amar","year":"2002","unstructured":"Amar A, Couldwell W, Chen J, Weiss M (2002) Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery. J Neurosurg 97(2):307\u2013314","journal-title":"J Neurosurg"},{"issue":"2","key":"1289_CR91","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","volume":"65","author":"F Casanueva","year":"2006","unstructured":"Casanueva F, Molitch M, Schlechte J et al (2006) Guidelines of the pituitary society for the diagnosis and management of prolactinomas. Clin Endocrinol 65(2):265\u2013273","journal-title":"Clin Endocrinol"},{"issue":"10","key":"1289_CR92","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1210\/jendso\/bvab074","volume":"5","author":"M Penn","year":"2021","unstructured":"Penn M, Cardinal T, Zhang Y et al (2021) Cure and hormonal control after prolactinoma resection: Case series and systematic review. J Endocr Soc 5(10):15","journal-title":"J Endocr Soc"},{"issue":"1","key":"1289_CR93","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11102-011-0347-7","volume":"15","author":"F Roelfsema","year":"2011","unstructured":"Roelfsema F, Biermasz N, Pereira A (2011) Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 15(1):71\u201383","journal-title":"Pituitary"},{"issue":"6","key":"1289_CR94","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.21037\/tau-20-1333","volume":"10","author":"A Nayak","year":"2021","unstructured":"Nayak A, Cresswell J, Mariappan P (2021) Quality of life in patients undergoing surveillance for non-muscle invasive bladder cancer: a systematic review. Transl Androl Urol 10(6):2737\u20132749","journal-title":"Transl Androl Urol"},{"issue":"11","key":"1289_CR95","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1093\/annonc\/mdq215","volume":"21","author":"C Thompson","year":"2010","unstructured":"Thompson C, Charlson M, Schenkein E et al (2010) Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors. Ann Oncol 21(11):2262\u20132266","journal-title":"Ann Oncol"},{"issue":"5","key":"1289_CR96","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/003655299750026254","volume":"34","author":"B Kjeldsen","year":"1999","unstructured":"Kjeldsen B, Thorsen H, Walley D, Kronborg O (1999) Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol 34(5):509\u2013515","journal-title":"Scand J Gastroenterol"},{"key":"1289_CR97","doi-asserted-by":"publisher","unstructured":"Almeida JP, Stephens CC, Eschbacher JM, Felicella MM, Yuen KCJ, White WL, Mooney MA, Bernat AL, Mete O, Zadeh G, Gentili F, Little AS (2019) Clinical, pathologic, and imaging characteristics of pituitary null cell adenomas as defined according to the 2017 World Health Organization criteria: a case series from two pituitary centers. Pituitary 22(5):514\u2013519. https:\/\/doi.org\/10.1007\/s11102-019-00981-9","DOI":"10.1007\/s11102-019-00981-9"},{"key":"1289_CR98","doi-asserted-by":"publisher","unstructured":"Bakhsheshian J, Wheeler S, Strickland BA, Pham MH, Rennert RC, Carmichael J, Weiss M, Zada G (2019) Surgical outcomes following repeat transsphenoidal surgery for nonfunctional pituitary adenomas: A retrospective comparative study. Oper Neurosurg (Hagerstown) 16(2):127\u2013135. https:\/\/doi.org\/10.1093\/ons\/opy078","DOI":"10.1093\/ons\/opy078"},{"key":"1289_CR99","doi-asserted-by":"crossref","unstructured":"Berkmann S, Schlaffer S, Nimsky C, Fahlbusch R, Buchfelder M (2014) Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma. J Neurosurg 121(5):1166\u20131175","DOI":"10.3171\/2014.6.JNS131994"},{"key":"1289_CR100","doi-asserted-by":"publisher","unstructured":"Hughes JD, Koeller K, Rinaldo L, Erickson D, Bancos I, Meyer FB, Atkinson J, Van Gompel JJ (2018) Beyond gross total and subtotal: Does volumetric resection matter in nonfunctioning pituitary macroadenomas? World Neurosurg 116:e733\u2013e737. https:\/\/doi.org\/10.1016\/j.wneu.2018.05.077","DOI":"10.1016\/j.wneu.2018.05.077"},{"key":"1289_CR101","doi-asserted-by":"publisher","unstructured":"Berinder K, Stacken\u00e4s I, Akre O, Hirschberg AL, Hulting AL (2005) Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up. Clin Endocrinol (Oxf) 63(4):450\u2013455. https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02364.x","DOI":"10.1111\/j.1365-2265.2005.02364.x"},{"key":"1289_CR102","doi-asserted-by":"publisher","unstructured":"Micko A, Vila G, H\u00f6ftberger R, Knosp E, Wolfsberger S (2019) Endoscopic transsphenoidal surgery of microprolactinomas: a reappraisal of cure rate based on radiological criteria. Neurosurgery 85(4):508\u2013515. https:\/\/doi.org\/10.1093\/neuros\/nyy385","DOI":"10.1093\/neuros\/nyy385"},{"key":"1289_CR103","doi-asserted-by":"publisher","unstructured":"Moberg E, af Trampe E, Wers\u00e4ll J, Werner S (1991) Long-term effects of radiotherapy and bromocriptine treatment in patients with previous surgery for macroprolactinomas. Neurosurgery 29(2):200\u2013204; discussion 204\u2013205. https:\/\/doi.org\/10.1097\/00006123-199108000-00005","DOI":"10.1097\/00006123-199108000-00005"},{"key":"1289_CR104","doi-asserted-by":"publisher","unstructured":"Rush S, Donahue B, Cooper P, Lee C, Persky M, Newall J (1991) Prolactin reduction after combined therapy for prolactin macroadenomas. Neurosurgery 28(4):502\u2013505. https:\/\/doi.org\/10.1097\/00006123-199104000-00003","DOI":"10.1097\/00006123-199104000-00003"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01289-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-022-01289-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01289-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T16:08:47Z","timestamp":1676131727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-022-01289-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1289"],"URL":"https:\/\/doi.org\/10.1007\/s11102-022-01289-x","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,23]]},"assertion":[{"value":"27 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors did not receive support from any organization for the submitted work. The authors have no relevant non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable for this study design.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable for this study design.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}